For Some, Cutting-Edge ‘CAR-T’ Treatment Unleashes ‘Pac-Man’ Cells Against Blood Cancer – WBUR
WBUR |
For Some, Cutting-Edge 'CAR–T' Treatment Unleashes 'Pac-Man' Cells Against Blood Cancer
WBUR This week, the U.S. Food and Drug Administration approved the second therapy in this class, called Yescarta, to treat advanced B-cell lymphomas, like Wilkins'. The first CAR–T drug, Kymriah, received approval in August to treat an advanced form of … New CAR–T cell therapy offers effective option for certain blood cancer patients CAR–T could revolutionize cancer treatment. It can also be fatal Personalized Gene Therapy Shows Promise For Certain Blood Cancers |
